Key result
In a comprehensive review of reported cases, cholesterol embolization syndrome was associated with a 92% incidence of atheroembolic renal disease and 63% mortality.
Cholesterol embolization syndrome is a highly morbid complication of cardiovascular interventions with a 63% mortality rate in reported cases.
No takes yet. Share an insight, caveat, or question.
High mortality in reported cholesterol embolization cases warrants procedural vigilance; leaves open true incidence and prevention strategies from prospective studies.
Agrawal et al. (2017) conducted a review in Cholesterol embolization syndrome. Cholesterol embolization syndrome was evaluated on Incidence of atheroembolic renal disease and mortality. In a comprehensive review of reported cases, cholesterol embolization syndrome was associated with a 92% incidence of atheroembolic renal disease and 63% mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: